Aleksandra Antovic

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: RHEUMATOLOGY. 2024;:keae146

Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study.

Cîrciumaru A; Kisten Y; Hansson M; Mathsson-Alm L; Joshua V; Wähämaa H; Haarhaus ML; Lindqvist J; Padyukov L; Catrina S-B; Fei G; Vivar N; Rezaei H; Af Klint E; Antovic A; Réthi B; Catrina AI; Hensvold A
Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2024;46(1):42-49

Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID-19 and neurological symptoms.

Taxiarchis A; Bellander B-M; Antovic J; Soutari N; Virhammar J; Kumlien E; Karakoyun C; Rostami E; Antovic A
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(4):418-423

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis.

Antovic A; Bruchfeld A; Ekland J; Lövström B; Hugelius A; Börjesson O; Knight A; Gunnarsson I
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(3):293-301

Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis.

Jonasdottir AD; Antovic A; Qureshi AR; Nordin A; Malmström V; Gunnarsson I; Bruchfeld A
Article: FRONTIERS IN MEDICINE. 2023;10:1240325

Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides.

Jonasdottir AD; Manojlovic M; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
Article: VACCINES. 2022;10(12):2046

Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination: A Case Report.

Kits A; Pantalone MR; Illies C; Antovic A; Landtblom A-M; Iacobaeus E
Article: JOURNAL OF RHEUMATOLOGY. 2022;49(6):598-606

Impaired Fibrinolysis Is Linked With Digital Vasculopathy and Onset of New Digital Ulcers in Systemic Sclerosis.

Colic J; Pruner I; Damjanov N; Pekmezovic T; Sefik-Bukilica M; Antovic A
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:761.2-76761

EXTRACELLULAR VESICLES AS POTENTIAL BIOMARKERS OF EARLY DISEASE STAGE IN SYSTEMIC SCLEROSIS

Colic J; Pruner I; Damjanov N; Antovic J; Bukilica MS; Antovic A
Journal article: JOURNAL OF RHEUMATOLOGY. 2022;49(5):547

Impaired Fibrinolysis Is Linked With Digital Vasculopathy and Onset of New Digital Ulcers in Systemic Sclerosis.

Colic J; Pruner I; Damjanov N; Pekmezovic T; Sefik-Bukilica M; Antovic A
Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(10):1299-1309

The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies.

Grosso G; Sandholm K; Antovic A; Gunnarsson I; Zickert A; Vikerfors A; Truedsson L; Bruzelius M; Nilsson B; Nilsson-Ekdahl K; Svenungsson E
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(5):390-397

Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies.

Notarnicola A; Barsotti S; Näsman L; Tang Q; Holmqvist M; Lundberg IE; Antovic A
Article: SEMINARS IN THROMBOSIS AND HEMOSTASIS. 2021;47(5):506-511

Impaired Fibrinolysis in the Antiphospholipid Syndrome.

Antovic A; Bruzelius M
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:693.1-69693

CLOT LYSIS TIME PREDICTS RECURRENT DIGITAL ULCERS IN SYSTEMIC SCLEROSIS AFTER ONE YEAR OF FOLLOW-UP: A NESTED CASE-CONTROL STUDY

Colic J; Antovic A; Pruner I; Vojinovic J; Damjanov N; Bukilica MS
Journal article: SERBIAN JOURNAL OF EXPERIMENTAL AND CLINICAL RESEARCH. 2021;22(1):29-36

Redox Status in Women with Rheumathoid Arthritis

Vranic A; Antovic A; Draginic N; Andjic M; Ravic M; Jakovljevic V; Veselinovic M
Article: OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. 2021;2021:9458587-12

The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis.

Stojanovic A; Veselinovic M; Draginic N; Rankovic M; Andjic M; Bradic J; Bolevich S; Antovic A; Jakovljevic V
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:718845

Increased Expression of Extracellular Vesicles Is Associated With the Procoagulant State in Patients With Established Rheumatoid Arthritis.

Stojanovic A; Veselinovic M; Zong Y; Jakovljevic V; Pruner I; Antovic A
Article: FRONTIERS IN MEDICINE. 2021;8:761453

Phosphatidylserine Exposing Extracellular Vesicles in Pre-eclamptic Patients.

Lalic-Cosic S; Dopsaj V; Kovac M; Mandic-Markovic V; Mikovic Z; Mobarrez F; Antovic A
Article: JOURNAL OF MOLECULAR MEDICINE-JMM. 2020;98(9):1279-1286

Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).

Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
Article: RHEUMATOLOGY ADVANCES IN PRACTICE. 2020;4(2):rkaa056

Venous thromboembolism in anti-neutrophil cytoplasmic antibody-associated vasculitis: an underlying prothrombotic condition?

Antovic A; Svensson E; Lövström B; Illescas VB; Nordin A; Börjesson O; Arnaud L; Bruchfeld A; Gunnarsson I
Article: TH OPEN. 2020;4(3):e178-e188

Diagnostic Accuracy in Acute Venous Thromboembolism: Comparing D-Dimer, Thrombin Generation, Overall Hemostatic Potential, and Fibrin Monomers.

Farm M; Antovic A; Schmidt DE; Bark N; Soutari N; Siddiqui AJ; Holmström M; Pruner I; Antovic JP
Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2020;42(3):322-330

Evaluation of global haemostatic assays and fibrin structure in patients with pre-eclampsia.

Lalic-Cosic S; Dopsaj V; Kovac M; Pruner I; Littmann K; Mandic-Markovic V; Mikovic Z; Antovic A
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2020;31(4):243-252

Effects of rivaroxaban and dabigatran on global hemostasis in patients with atrial fibrillation.

Petkovic A; Al-Khalili F; Antovic A; Ammar M; Pruner I; Vranic A; Soutari N; Zdravkovic N; Malmström RE; Jakovljevic V; Antovic JP
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:699.2-69700

ALTERED FIBRIN CLOT PROPERTIES IN PATIENTS WITH SYSTEMIC SCLEROSIS

Colic J; Antovic A; Pruner I; Vojinovic J; Bukilica MS; Damjanov N
Article: SCIENTIFIC REPORTS. 2020;10(1):7871

Phosphatidylserine positive microparticles improve hemostasis in in-vitro hemophilia A plasma models.

Zong Y; Pruner I; Antovic A; Taxiarchis A; Vila ZP; Soutari N; Mobarrez F; Chaireti R; Widengren J; Piguet J; Antovic JP
Article: JOURNAL OF RHEUMATOLOGY. 2020;47(5):714-721

Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Antovic A; Mobarrez F; Manojlovic M; Soutari N; De Porta Baggemar V; Nordin A; Bruchfeld A; Vojinovic J; Gunnarsson I
Article: TH OPEN. 2020;4(2):e94-e103

Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A.

Zong Y; Antovic A; Soutari NMH; Antovic J; Pruner I
Article: CLINICAL CHEMISTRY. 2020;66(2):379-389

The Silence Speaks, but We Do Not Listen: Synonymous c.1824C>T Gene Variant in the Last Exon of the Prothrombin Gene as a New Prothrombotic Risk Factor.

Pruner I; Farm M; Tomic B; Gvozdenov M; Kovac M; Miljic P; Soutari NMH; Antovic A; Radojkovic D; Antovic J; Djordjevic V
Article: CLINICAL RHEUMATOLOGY. 2019;38(11):3005-3014

Assessment of hemostatic disturbances in women with established rheumatoid arthritis.

Vranic A; Pruner I; Veselinovic M; Soutari N; Petkovic A; Jakovljevic V; Antovic A
Article: LUPUS. 2019;28(7):868-877

Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile.

Högdén A; Antovic A; Berg E; Bremme K; Chaireti R
Article: ARTHRITIS CARE & RESEARCH. 2018;70(12):1849-1855

Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset.

Antovic A; Notarnicola A; Svensson J; Lundberg IE; Holmqvist M
Article: THROMBOSIS RESEARCH. 2017;158:168-173

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
Article: THROMBOSIS AND HAEMOSTASIS. 2017;117(9):1700-1704

Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.

Antovic A; Norberg E-M; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
Journal article: THROMBOSIS RESEARCH. 2017;151:s119

P-030: Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) – underlying prothrombotic condition in active disease?

Antovic A; Svensson E; Börjesson O; Bruchfeld A; Gunnarsson I
Article: CLINICAL ENDOCRINOLOGY. 2016;84(5):729-735

The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.

Mobarrez F; Abraham-Nordling M; Aguilera-Gatica K; Friberg I; Antovic A; Pisetsky DS; Jörneskog G; Wallen H
Article: THROMBOSIS RESEARCH. 2015;135(6):1124-1130

Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis.

Vucelic D; Jesic R; Jovicic S; Zivotic M; Grubor N; Trajkovic G; Canic I; Elezovic I; Antovic A
Article: THROMBOSIS AND HAEMOSTASIS. 2015;113(2):312-318

Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.

Tehrani S; Jörneskog G; Ågren A; Lins P-E; Wallén H; Antovic A
Article: THROMBOSIS RESEARCH. 2014;133(5):936-944

Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.

Vikerfors A; Svenungsson E; Ågren A; Mobarrez F; Bremme K; Holmström M; Eelde A; Bruzelius M; Elgue G; Wallén H; Antovic A
Article: THROMBOSIS AND HAEMOSTASIS. 2014;111(4):656-661

Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.

Antovic A; Mikovic D; Elezovic I; Zabczyk M; Hutenby K; Antovic JP
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11(4):697-703

Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?

Mobarrez F; Mikovic D; Antovic A; Antovic JP
Article: THROMBOSIS RESEARCH. 2012;130(4):649-653

Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis.

Westerlund E; Henriksson P; Wallén H; Hovatta O; Wallberg KR; Antovic A
Article: THROMBOSIS AND HAEMOSTASIS. 2012;108(1):21-31

Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A.

Antovic JP; Mikovic D; Elezovic I; Holmström M; Wilkens M; Elfvinge P; Mahmoud Hourani Soutari N; Antovic A
Article: LUPUS. 2012;21(7):802-805

Studies of microparticles in patients with the antiphospholipid syndrome (APS).

Vikerfors A; Mobarrez F; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Antovic A; Wallén H; Svenungsson E
Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2012;34(1):35-40

On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.

Mikovic D; Woodhams BJ; Holmström M; Elezovic I; Antovic A; Mobarrez F; Elfvinge P; Antovic JP
Article: DIABETES CARE. 2012;35(2):404-408

High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.

Tehrani S; Antovic A; Mobarrez F; Mageed K; Lins P-E; Adamson U; Wallén HN; Jörneskog G
Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2012;20(1):13-18

Duration dependent effect of intravenous heroin intake on morphological changes in the liver

Ilic G; Karadzic R; Kostic-Banovic L; Antovic A
Article: THROMBOSIS AND HAEMOSTASIS. 2011;106(2):344-352

Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.

Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2011;22(2):127-131

Changes in von Willebrand factor and ADAMTS13 during IVF.

Westerlund E; Antovic A; Hovatta O; Eberg KP; Blombäck M; Wallén H; Henriksson P
Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2011;19(4):303-305

Thrombosis of aberrant right subclavian artery co-existing with infarction of left cerebellar hemisphere: Case report

Stojanovic I; Ilic G; Karadzic R; Antovic A; Milic M
Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2011;19(1):27-32

Amyloidosis, change in macrophage number, and dysplasia in the liver of intravenous heroin users

Ilic G; Karadzic R; Kostic-Banovic L; Antovic A
Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2011;19(4):259-264

The reduction of glycogen in the liver induced by chronic intravenous heroin abuse

Ilic G; Karadzic R; Kostic-Banovic L; Antovic A; Milic M; Stojanovic I
Article: SEMINARS IN THROMBOSIS AND HEMOSTASIS. 2010;36(7):772-779

The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.

Antovic A
Article: THROMBOSIS RESEARCH. 2010;126(3):E225-E231

Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

Tehrani S; Mobarrez F; Antovic A; Santesson P; Lins P-E; Adamson U; Henriksson P; Wallén NH; Jörneskog G
Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2010;18(4):247-252

Autolytic ultrastructural changes in rat and human hepatocytes

Karadzic R; Ilic G; Antovic A; Kostic Banovic L
Article: CURRENT VASCULAR PHARMACOLOGY. 2008;6(3):173-185

Screening haemostasis--looking for global assays: the Overall Haemostasis Potential (OHP) method--a possible tool for laboratory investigation of global haemostasis in both hypo- and hypercoagulable conditions.

Antovic A
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2007;18(4):365-370

Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.

Rooth E; Wallen H; Antovic A; von Arbin M; Kaponides G; Wahlgren N; Blombäck M; Antovic J
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2005;16(8):585-596

Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma.

Antovic A; Blombäck M; Sten-Linder M; Petrini P; Holmström M; He S
Article: ANNALS OF THORACIC SURGERY. 2005;80(2):586-593

Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study.

Vedin J; Antovic A; Ericsson A; Vaage J
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2005;16(1):61-67

Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials.

He S; Cao H; Antovic A; Blombäck M
Article: THROMBOSIS RESEARCH. 2005;116(6):509-517

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A; Perneby C; Ekman GJ; Wallen HN; Hjemdahl P; Blombäck M; He S
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2003;1(12):2531-2535

Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance.

Antovic A; Blombäck M; Bremme K; Van Rooijen M; He S
Article: THROMBOSIS AND HAEMOSTASIS. 2003;90(4):620-627

Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.

Antovic JP; Antovic A
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2003;14(6):551-556

Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.

Antovic JP; Yngen M; Ostenson C-GG; Antovic A; Wallen HN; Jorneskög G; Blombäck M
Article: HAEMOPHILIA. 2002;8(6):781-786

Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.

Antovic JP; Antovic A; He S; Tengborn L; Blombäck M
Article: THROMBOSIS AND HAEMOSTASIS. 2002;88(4):644-647

Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?

Antovic JP; Rafik Hamad R; Antovic A; Blombäck M; Bremme K
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2002;13(3):181-186

The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.

Antovic A; Blombäck M; Bremme K; He S
Article: THROMBOSIS RESEARCH. 2001;103(5):355-361

A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work.

He S; Antovic A; Blombäck M
Visa fler

Alla övriga publikationer

Conference publication: 2024;:a143-a144

P136 Comparison of obstetric outcomes in two consecutive pregnancies in women with renal and non-renal systemic lupus erythematosus – A retrospective single-centre cohort study

Antovic A; Charieti R; Jacke E; Bremme K; Gunnarsson I
Conference publication: 2024;:a141-a142

P135 Altered hemostatic balance towards procoagulant state in pregnant women with systemic lupus erythematosus

Lini D; Gunnarsson I; Soutari N; Lalic-Cosic S; Nicholas AM; Chaireti R; Bremme K; Franceschini F; Svenungsson E; Andreoli L; Antovic A
Conference publication: 2024;:a83-a84

P58 Menopausal age and the effect of menopause on disease activity in SLE

Yilmaz EB; Zickert A; Gunnarsson I; Svenungsson E; Antovic A
Conference publication: IMMUNOBIOLOGY. 2023;228(5):152543

Treatment with warfarin but not Factor Xa inhibitors, is associated with dysregulated, noncanonical, complement activation

Ekdahl KN; Sandholm K; Ibrahim-Kosta M; Grosso G; Antovic A; Hardstedt M; Mohlin C; Eriksson O; Svenungsson E; Huber-Lang M; Blom AM; Nilsson B; Morange P-E; Bruzelius M
Editorial comment: LANCET RHEUMATOLOGY. 2023;5(9):e501-e506

Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases.

Schreiber K; Giles I; Costedoat-Chalumeau N; Nelson-Piercy C; Dolhain RJ; Mosca M; Förger F; Fischer-Betz R; Molto A; Tincani A; Pasquier E; Marin B; Elefant E; Salmon J; Bermas BL; Sammaritano L; Clowse MEB; Chambers C; Buyon J; Inoue SA; Agmon-Levin N; Aguilera S; Emadi SA; Andersen J; Andrade D; Antovic A; Arnaud L; Christiansen AA; Avcin T; Badreh-Wirström S; Bertsias G; Bini I; Bobirca A; Branch W; Brucato A; Bultink I; Capela S; Cecchi I; Cervera R; Chighizola C; Cobilinschi C; Cuadrado MJ; Dey D; Etomi O; Espinosa G; Flint J; Fonseca J-E; Fritsch-Stork R; Gerosa M; Glintborg B; Skorpen CG; Goulden B; Graversgaard C; Gunnarsson I; Gupta L; Hetland M; Hodson K; Hunt BJ; Isenberg D; Jacobsen S; Khamashta M; Levy R; Linde L; Lykke J; Meissner Y; Moore L; Morand E; Navarra S; Opris-Belinski D; Østensen M; Ozawa H; Perez-Garcia LF; Petri M; Pons-Estel GJ; Radin M; Raio L; Rottenstreich A; Ruiz-Irastorza G; Tunjić SR; Rygg M; Sciascia S; Strangfeld A; Svenungsson E; Tektonidou M; Troldborg A; Vinet E; Vojinovic J; Voss A; Wallenius M; Andreoli L
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1468-1469

COAGULATION AND HAEMOSTASIS PARAMETERS IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND HEALTHY CONTROLS WITH AND WITHOUT PREECLAMPSIA

Lini D; Gunnarsson I; Soutari NMH; Lalic-Cosic S; Mc Nicholas A; Charieti R; Bremme K; Franceschini F; Svenungsson E; Andreoli L; Antovic A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1806

COMORBIDITY IN PSORIATIC ARTHRITIS (COMPASS) - INCIDENCE OF DEPRESSIVE SYMPTOMS AND ASSOCIATED FACTORS

Avik A; Waldheim E; Geschwind S; Antovic A; Oke V
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:78.1-7879

IDENTIFICATION OF EARLY RISK FACTORS IN A NOVEL PREDICTION MODEL FOR ACPA POSITIVE RA

Circiumaru A; Kisten Y; Hansson M; Mathsson-Alm L; Joshua V; Wahamaa H; Haarhaus ML; Lindqvist J; Guozhong F; Pomiano NV; Rezaei H; Af Klint E; Antovic A; Rethi B; Catrina A; Hensvold A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1115.1-111115

THROMBOCYTOPENIA AND IMPAIRED KIDNEY FUNCTION ARE MAJOR RISK FACTORS FOR RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

Karandyszowska N; Alagunduz H; Widaeus J; Carlens F; Warnqvist A; Magnussion M; Gunnarsson I; Svenungsson E; Bruzelius M; Antovic A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1539-1540

SERUM 25 (OH) VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Yilmaz EB; Amdahl K; Zickert A; Antovic A; Gunnarsson I; Svenungsson E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:985.2-98986

CIRCULATING EXTRACELLULAR VESICLES AS A POTENTIAL BIOMARKER OF INTERSTITIAL LUNG DISEASE AND ITS PROGRESSION IN SYSTEMIC SCLEROSIS -A PROSPECTIVE COHORT STUDY

Colic J; Pruner I; Damjanov N; Antovic J; Bukilica MS; Antovic A
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1596.1-151596

URINARY INTERLEUKIN (IL)-16 IN ANTI - NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)- ASSOCIATED VASCULITIS WITH KIDNEY INVOLVEMENT

Juto A; Faustini F; Hayry A; Larsson A; Malmstrom V; Bruchfeld A; Antovic A; Oke V; Gunnarsson I
Conference publication: 2022;:a42.2-a4a43

PO.2.37 Risk factors for recurrent thrombosis and cause of death in patients with antiphospholipid syndrome; a Swedish cohort study

Karandyszowska N; Alagündüz H; Oesman J; Magnusson M; Svenungsson E; Bruzelius M; Antovic A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:40-41

PROFOUND ANTICOAGULANT EFFECTS OF INITIAL ANTIRHEUMATIC TREATMENTS IN EARLY RHEUMATOID ARTHRITIS PATIENTS: A NORD-STAR SPIN-OFF STUDY

Dijkshoorn B; Antovic A; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Grondal G; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; Van Vollenhoven R; Nurmohamed M
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:1434

MYELOPEROXIDASE (MPO) POSITIVE EXTRACELLULAR VESICLES (EVS) EXPRESSING COMPLEMENT SPLIT PRODUCTS IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS (AAV)

Juto A; Soutari NMH; Taxiarchis A; Malmstrom V; Bruchfeld A; Antovic A; Gunnarsson I
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:3183-3185

Profound Anticoagulant Effects of Initial Antirheumatic Treatments in Early Rheumatoid Arthritis Patients; A NORD-STAR Spin-off Study

Dijkshoorn B; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm E; Grondal GM; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; van Vollenhoven R; Antovic A; Nurmohamed M
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:1184

RISK FOR CONCOMITANT AUTOIMMUNITY IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME; A SWEDISH COHORT STUDY

Karandyszowska N; Oesman J; Alagunduz H; Magnusson M; Svenungsson E; Bruzelius M; Antovic A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:898

OUTCOME FOLLOWING COVID-19 INFECTION IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS

Antovic A; Lovstrom B; Hugelius A; Borjesson O; Bruchfeld A; Gunnarsson I
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:87

TENOSYNOVITIS, SYNOVIAL HYPERTROPHY AND FEET BURSITIS ARE USEFUL ULTRASOUND BIOMARKERS FOR PREDICTING ARTHRITIS DEVELOPMENT IN A POPULATION AT-RISK FOR RHEUMATOID ARTHRITIS

Kisten Y; Circiumaru A; Loberg M; Vivar-Pomiano N; Antovic A; Rezaei H; Af Klint E; Hensvold A; Catrina A
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:62-63

Arthritis Progression in at Risk Individuals Is Associated with ACPAs Not AMPAs

Circiumaru A; Kisten Y; Hansson M; Wahamaa H; Sun M; Joshua V; Rezaei H; Af Klint E; Antovic A; Catrina A; Hensvold AH
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:335

SKIN PROTEOME INVESTIGATION IN CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) REVEALS NOVEL UNIQUE DISEASE PATHWAYS

Niewold T; Popovic-Silwerfeldt K; Lehman J; Meves A; Charlesworth C; Madden B; Hayry A; Antovic A; Lundberg IE; Wahren-Herlenius M; Svenungsson E; Oke V
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1247

SPECIFIC ACPA REACTIVITIES AND INFLAMMATORY BIOMARKERS ALONG WITH ULTRASOUND TENOSYNOVITIS ARE ASSOCIATED WITH ARTHRITIS ONSET IN A POPULATION AT RISK FOR RHEUMATOID ARTHRITIS

Circiumaru A; Kisten Y; Hansson M; Joshua V; Sun M; Rezaei H; Af Klint E; Antovic A; Catrina A; Hensvold A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1907

C4B BINDING PROTEIN AND WARFARIN IN THE ANTIPHOSPHOLIPID SYNDROME

Grosso G; Sandholm K; Gunnarsson I; Zickert A; Vikerfors A; Antovic A; Nilsson B; Ekdahl KN; Svenungsson E
Review: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):349-372

The antiphospholipid syndrome - often overlooked cause of vascular occlusions?

Svenungsson E; Antovic A
Conference publication: LUPUS SCIENCE & MEDICINE. 2020;7(Suppl 1):a25

O32 Skin proteome investigation in cutaneous lupus erythematosus (CLE) reveals novel unique disease pathways

Niewold TB; Meves A; Lehman J; Popovic-Silwerfeldt K; Antovic A; Dorschner JM; Charlesworth CM; Lundberg I; Wahren-Herlenius M; Svenungsson E; Oke V
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2020;72

The Complex Relationship Between C4b Binding Protein, Warfarin and Antiphospholipid Antibodies

Grosso G; Sandholm K; Antovic A; Gunnarsson I; Zickert A; Vikerfors A; Truedsson L; Bruzelius M; Nilsson B; Ekdahl KN; Svenungsson E
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2020;72

Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis

Kisten Y; Circiumaru A; Loberg-Haarhaus M; Vivar N; Antovic A; Rezaei H; Af Klint E; Hensvold A; Catrina A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1785

ASSOCIATION OF VASCULAR BIOMARKERS WITH SYSTEMIC SCLEROSIS CLINICAL FEATURES AND NAILFOLD VIDEOCAPILLAROSCOPY ALTERATIONS-CROSS SECTIONAL STUDY

Colic J; Antovic A; Tang Q; Zlatanovic M; Pavlov-Dolijanovic S; Jeremic I; Kadic A; Gunnarsson K; Nordin A; Vojinovic J; Bukilica MS; Damjanov N
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:310

DEVELOPMENT OF ULTRASOUND DETECTABLE ARTHRITIS AMONG ACPA POSITIVE SUBJECTS WITH MUSCULOSKELETAL SYMPTOMS: THE RISK RA PROSPECTIVE STUDY

Hensvold A; Kisten Y; Circiumaru A; Hansson M; Sun M; Fei G; Vivar N; Af Klint E; Rezaei H; Klareskog L; Antovic A; Catrina A
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1222

TRADITIONAL AND DISEASE-RELATED RISK FACTORS FOR ARTERIAL AND VENOUS THROMBOTIC EVENTS (TE) IN IDIOPATHIC INFLAMMATORY MYOPATHIES (IIM)

Notarnicola A; Barsotti S; Nasman L; Tang Q; Holmqvist M; Lundberg I; Antovic A
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:A8-A9

TENOSYNOVITIS AND HLA-SE PREDICT ARTHRITIS ONSET IN ACPA-POSITIVE INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS

Hensvold AH; Kisten Y; Hansson M; Circiumaru A; Sun M; Fei G; Af Klint E; Rezaei H; Antovic A; Catrina AI
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

Development of Ultrasound Detectable Arthritis Among ACPA Positive Subjects with Musculoskeletal Symptoms: The Risk RA Prospective Study

Hensvold A; Kisten Y; Circiumaru A; Hansson M; Sun M; Fei G; Vivar N; af Klint E; Rezaei H; Klareskog L; Antovic A; Catrina A
Meeting abstract: BLOOD. 2018;132:2473

Combined Effect of By-Pass Agents and a Sequence Identical Analogue of Emicizumab on Fibrin Clot Turbidity and Structure in Factor VIII Deficient Plasma

Pruner I; Zong Y; Soutari NMH; Chaireti R; Antovic A; Antovic J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:77

MICROPARTICLES AS POTENTIAL BIOMARKERS OF DISEASE ACTIVITY IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY - ASSOCIATED VASCULITIS

Antovic A; Kostic M; Mobarrez F; Nordin A; Vojinovic J; Bruchfeld A; Gunnarsson I
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:287-288

ULTRASOUND DETECTED TENOSYNOVITIS PREDICTS ARTHRITIS ONSET IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS

Kisten Y; Rezaei H; af Klint E; Fei G; Antovic A; Hensvold AH; Catrina AI
Review: LUPUS SCIENCE & MEDICINE. 2018;5(1):e000197

Obstetric antiphospholipid syndrome.

Antovic A; Sennström M; Bremme K; Svenungsson E
Conference publication: HAEMOPHILIA. 2018;24:19

The correlation between overall haemostatic potential with bleeding severity in haemophilia A

Mikovic D; Soutari NMH; Antovic A; Antovic J
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47:51

Microparticles as potential biomarkers of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis

Antovic A; Mobarrez F; Nordin A; Gunnarsson I
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

ACPA-Positive Risk-RA Subject without Subclinical Arthritis Are in High Risk for Later Arthritis Onset, Especially Carriers of HLA-SE Risk-Gene

Hensvold A; Kisten Y; Hansson M; Circiumaru A; Sun M; Rezaei H; af Klint E; Fei G; Antovic A; Catrina AI
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

Tenosynovitis Detected By Ultrasound Predicts Arthritis Onset in Individuals at Risk of Developing Rheumatoid Arthritis

Kisten Y; Rezaei H; af Klint E; Fei G; Antovic A; Hensvold A; Catrina AI
Conference publication: RHEUMATOLOGY. 2017;56:148

VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS - UNDERLYING PROTHROMBOTIC CONDITION IN ACTIVE DISEASE?

Antovic A; Svensson E; Borjesson O; Bruchfeld A; Gunnarsson I
Conference publication: THROMBOSIS RESEARCH. 2017;151:S119

Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) - underlying prothrombotic condition in active disease?

Antovic A; Svensson E; Borjesson O; Bruchfeld A; Gunnarsson I
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:1105-1106

RISK FACTORS FOR THROMBOEMBOLIC EVENTS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

Notarnicola A; Nasman L; Tang Q; Tjarlund A; Elvin K; Berg L; Norkko J; Lundberg IE; Antovic A
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:45-46

Antiphospholipid antibodies in systemic sclerosis and their association with ischaemic arterial events and atherosclerosis

Nordin AAH; Coskun S; Antovic A; Elvin K; Svenungsson E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:1009

THE USE OF CARDIOVASCULAR RISK MODULE WITHIN THE SWEDISH RHEUMATOLOGY QUALITY REGISTRY (SRQ) HELPS IN DAILY CLINICAL PRAXIS

Kvarnstrom M; Antovic A; Turesson C; Ljung L; Sodergren A; Leonard D; Henrohn D; Dehlin M; Wallberg-Jonsson S; Svenungsson E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:642-643

EFFECTS OF NEW (DIRECT) ORAL ANTICOAGULANTS ON LUPUS ANTICOAGULANT ASSAYS

Antovic J; Antovic A; Norberg E-M; Berndtsson M; Skeppholm M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:A50

THE USE OF CARDIOVASCULAR RISK MODULE WITHIN THE SWEDISH RHEUMATOLOGY QUALITY REGISTRY (SRQ) HELPS IN DAILY CLINICAL PRAXIS

Kvarnstrom M; Antovic A; Turesson C; Ljung L; Sodergren A; Leonard D; Henrohn D; Dehlin M; Wallberg-Jonsson S; Svenungsson E
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13:166

Effects of new (direct) oral anticoagulants on lupus anticoagulant assays

Antovic J; Antovic A; Norberg E-M; Berndtsson M; Skeppholm M
Conference publication: THROMBOSIS RESEARCH. 2015;135:S69

Thrombin activatable fibrinolysis inhibitor - TAFI as a possible link between coagulation and complement activation in patients with the antiphospholipid syndrome

Antovic A; Vikerfors A; Woodhams B; Adam M; Svenungsson E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:591

INCREASED LEVELS OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR - TAFI CORRELATE WITH COMPLEMENT ACTIVATION IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME

Antovic A; Vikerfors A; Woodhams B; Adam M; Svenungsson E
Conference publication: THROMBOSIS RESEARCH. 2014;133:S36

INCREASED LEVELS OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR - TAFI CORRELATE WITH COMPLEMENT ACTIVATION IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME

Antovic A; Vikerfors A; Woodhams B; Adam M; Svenungsson E
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:89-90

Increased levels of thrombin-activatable fibrinolysis inhibitor (TAFI) correlate with complement activation in patients with the antiphospholipid syndrome

Antovic A; Vikerfors A; Svenungsson E
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:334

Increased levels of thrombin activatable fibrinolysis inhibitor - TAFI in patients with the antiphospholipid syndrome

Antovic A; Vikerfors A; Antovic JP; Woodhams B; Adam M; Svenungsson E
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:192

Improvement of fibrin clot structure after FVIII injection in hemophilia A patients treated on demand

Antovic A; Mikovic D; Zabczyk M; He S; Elezovic I; Hutenby K; Antovic JP
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:1013-1014

Molecular markers of blood hipercoagulability and values of overall coagulation potential in double heterozygotes for the FV Leiden and FII G20210A mutation

Miljic P; Bodrozic J; Djordjevic V; Antovic A
Meeting abstract: THROMBOSIS RESEARCH. 2013;131:S72

Gender aspects of fibrin clot structure in patients with type 1 diabetes mellitus

Tehrani S; Wallen NH; Elgue G; Majeed K; Henriksson P; Agren A; Adamson U; Lins P-E; Jorneskog G; Antovic A
Meeting abstract: THROMBOSIS RESEARCH. 2012;130:S122

Does a tight fibrin clot in premenopausal women with type 1 diabetes explain the lack of gender difference in cardiovascular disease?

Antovic A; Wallen NH; Elgue G; Majeed K; Henriksson P; Agren A; Adamson U; Lins P-E; Jorneskog G
Conference publication: THROMBOSIS RESEARCH. 2012;130:S116

Decrease of microparticles and hemostasis improvement after the treatment in hemophilia A. coincidence or causation?

Antovic JP; Mobbarez F; Mikovic D; Antovic A
Conference publication: HAEMOPHILIA. 2012;18:101

Decrease of microparticles (MP) after treatment in hemophilia A patients: coincidence or causation?

Antovic J; Mobbarez F; Mikovic D; Antovic A
Meeting abstract: THROMBOSIS RESEARCH. 2011;127:S138

Decreased fibrin clot porosity in patients with antiphospholipid syndrome

Vikerfors A; Svenungsson E; Bremme K; Holmstrom M; Antovic A
Meeting abstract: THROMBOSIS RESEARCH. 2011;127:S129-S130

ETP - a sensitive marker of haemostasis in women undergoing in vitro fertilization

Westerlund E; Henriksson P; Wallen NH; Hovatta O; Blombaeck M; Antovic A
Conference publication: DIABETES. 2011;60:A99

A High Dose of Aspirin Is Required for Positive Influence on Plasma Fibrin Network in Patients with Type 1 Diabetes

Tehrani S; Antovic A; Mobarrez F; Mageed K; Lins P-E; Adamson U; Wallen H; Jorneskog G
Conference publication: HAEMOPHILIA. 2011;17(2):352

Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A

Antovic JP; Mikovic D; Elezovic I; Holmstrom M; Elfvinge P; Soutari N; Antovic A
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:141

A high dose of aspirin is required for positive influence on plasma fibrin network in patients with type 1 diabetes

Tehrani S; Antovic A; Mobarrez F; Mageed K; Lins P-E; Adamson U; Wallen H; Jorneskog G
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:646

Increased levels of monocyte and endothelial derived microparticles expressing tissue factor and altered fibrin network in patients with Graves ' disease

Mobarrez F; Abraham-Nordling M; Friberg I; Antovic A; Jorneskog G; Wallen H
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:626

Studies of microparticles in patients with antiphospholipid syndrome (APS)

Vikerfors A; Mobarrez F; Bremme K; Holmstrom M; Agren A; Eelde A; Bruzelius M; Antovic A; Wallen H; Svenungsson E
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:486

Impaired microvascular function during atorvastatin therapy in patients with type 1 diabetes

Tehrani S; Mobarrez F; Antovic A; Lins P-E; Adamson U; Henriksson P; Wallen H; Jorneskog G
Conference publication: DIABETES. 2010;59:A287

Impaired Glycemic Control and Skin Microvascular Reactivity during Atorvastatin Therapy in Patients with Type 1 Diabetes

Tehrani S; Santesson P; Mobarrez F; Antovic A; Lins P-E; Adamson U; Wallen H; Jorneskog G
Conference publication: HAEMOPHILIA. 2010;16:84-85

Could global hemostatic methods (ETP and OHP) be instrumental in the individualization of patients and tailoring treatment of hemophilia A?

Antovic J; Mikovic D; Holmstrom M; Soutari N; Elfvinge P; Antovic A
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2009;7:581

Reduced expression of tissue factor on platelet derived microparticles during atorvastatin treatment in patients with peripheral artery disease

Mobarrez F; Antovic A; Broijersen A; Wiklund B; Wallen H
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2009;7:444

Changes in von Willebrand factor and ADAMTS-13 during in vitro fertilization

Westerlund E; Henriksson P; Wallen H; Hovatta O; Eberg PK; Mobarrez F; Blomback M; Antovic A
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2009;7:240

Effects of atorvastatin on haemostasis in patients with type 1 diabetes

Tehrani S; Mobarrez F; Antovic A; Santesson P; Lins P; Adamson U; Henriksson P; Wallen H; Jorneskog G
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2009;7:295

Glycemic control is of major importance for fibrin clot structure in type 1 diabetes

Antovic A; Mobarrez F; Tehrani S; Lins P; Adamson U; Wallen N; Jorneskog G
Meeting abstract: THROMBOSIS RESEARCH. 2009;123:S135

Haemostatic disturbances in women undergoing in vitro fertilization

Westerlund E; Wallen NH; Hovatta O; Bjuresten K; Henriksson P; Blomback M; Antovic A
Conference publication: HAEMOPHILIA. 2008;14:23

Can the overall hemostatic potential (OHP) method be used for monitoring treatment in patients with hemophilia A?

Antovic J; Holmstroem M; Elfvinge P; Antovic A
Letter: THROMBOSIS AND HAEMOSTASIS. 2007;98(6):1386-1388

Comparison of two laboratory assays for the investigation of fibrin gel porosity.

Antovic A; Jörneskog G; Wallen NH
Conference publication: DIABETOLOGIA. 2007;50:S455

Fibrin gel porosity relates to glycosylated haemoglobin in patients with type 1 diabetes mellitus

Antovic AM; Wallen NH; Salomonsson A-C; Lins P-E; Adamson U; Jorneskog G
Conference publication: THROMBOSIS RESEARCH. 2005;115:109-110

New overall haemostatic balance method in different conditions with haemostatic disturbances

Antovic A; He S; Blomback M
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2004;2(11):2058-2060

Overall hemostatic potential (OHP) assay-a possible tool for determination of prothrombotic pattern in FXII deficiency.

Antovic JP; Antovic A; Sten-Linder M; Wramsby M; Blombäck M
Conference publication: BLOOD. 2003;102(11):796A-797A

Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis in factor VIII deficient plasma and in hemophilia a patients?

Antovic JP; Antovic A; Blombäck M
Visa fler

Forskningsbidrag

Increased risk for thrombotic complications in patients with rheumatic diseases -from register data to individual patient and biomarkers

Stockholm County Council and Karolinska Institutet (ALF)

1 January 2024 - 31 December 2025
Increased risk for thrombotic complications in patients with rheumatic diseases - from register data to individual patient and biomarkers

Heart-Lung Foundation

1 January 2023 - 31 December 2025
Subgrouping SLE - a new approach to understand the pathogenesis and improve treatment

Swedish Research Council

1 January 2023 - 31 December 2025
Clinical and laboratory predictors of venous thromboembolism (VTE) in patients with rheumatic diseases

Stockholm County Council and Karolinska Institutet (ALF)

1 January 2022 - 31 December 2023
Clinical and laboratory predictors of venous thromboembolism (VTE) in patients with systemic inflammatory diseases

Stockholm County Council and Karolinska Institutet (ALF)

1 January 2019 - 31 December 2021
Clinical and laboratory predictors of venous thromboembolism (VTE) in patients with systemic inflammatory diseases

Stockholm County Council and Karolinska Institutet

1 January 2018 - 31 December 2018
Vascular disease in systemic autoimmunity, - Dissecting the characteristics of high risk sub-phenotypes?

Swedish Research Council

1 January 2015 - 31 December 2018

Anställningar

Biträdande överläkare, ME Gastro Hud Reuma, Karolinska Universitetssjukhuset, 2021-
Adjungerad Lektor, Medicin, Solna, Karolinska Institutet, 2020-2025
Överläkare, Akademiskt specialistcentrum, Centrum för reumatologi, Stockholms läns sjukvårdsområde (SLSO), 2017-2021

Examina och utbildning

Docent, Koagulationsforskning, Karolinska Institutet, 2015
MEDICINE DOKTORSEXAMEN, INST F KIRURGISK VETENSKAP (K3), Karolinska Institutet, 2004

Handledare

Esin Ylmaz, The impact of female hormonal fluctuations on SLE features and damage, 2023
Natali Karandyszowska, Diagnostic and therapeutic challenges in patients with antiphospholipid syndrome, 2021

Uppdrag i kommitté

Medlem, EULAR Study Group on Reproductive Health & Family Planning, European Alliance of Associations for Rheumatology, 2023
Medlem, Swedish Rheumatology Association, 2023

Utvärdering av avhandlingsarbete

Shahrzad Kia Komujuni, Examination board member, Department of Medicine Solna, Karolinska Institute, Optimising treatment outcomes in people leaving with systemic lupus erythematosus, 2022
Alexander Juto, Examination board member, Department of Clinical Neuroscience & Center for Molecular Medicine (CMM), Neuroimmunology Unit., Karolinska Institute, Anti-CD20 therapy in multiple sclerosis : clinical and paraclinical outcomes, 2021
Muna Saleh, Examination board member, Department of Biomedical & Clinical Sciences Rheumatology/Division of Inflammation & Infection, Linköping University Hospital, Half-time examination. Title: Biomarkers associated with adverse pregnancy outcomes and other disease-related manifestations in systemic lupus erythematosus, 2021
Karin Hjorton, Examination board member, Uppsala Universitet, Department of Medical Sciences, The activation and regulation of plasmacytoid dendritic cells in SLE and possible therapeutic interventions, 2020
Margarita Ivanchenko, Examination board member, Department of Medicine, Solna, Karolinska Institutet, Cellular and Molecular Factors in the Pathogenesis of Systemic Autoimmunity and Comorbidities, 2019
Eva Waldheim, Examination board member, Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, When systemic lupus erythematosus (SLE) involves pain: occurrence and impact on daily life, 2018
Ingrid Lekander, Examination board member, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, 2017
Torstein Jensen, Opponent, Hematological Researh Laboratory, Oslo, Norway, University of Oslo, Norway, Studies on subfractions of fibrinogen. With special emphasis on fibrinogen quantification, viscosity and inflammation, 2008

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Handledare

Uppdrag i kommitté

Utvärdering av avhandlingsarbete

Nyheter från KI

Kalenderhändelser från KI